Equipoise (Boldenone) Beligas Pharmaceutical at a Glance
Equipoise (Boldenone) is an injectable anabolic-androgenic steroid derived from testosterone with structural modifications that alter its pharmacological profile. Originally developed by Ciba Pharmaceuticals in the 1960s, this compound features a double bond between carbon atoms 1 and 2, which significantly reduces its conversion to estrogen compared to testosterone. Researchers investigating androgen receptor biology and anabolic pathway mechanisms frequently examine this compound in controlled laboratory environments. This Beligas Pharmaceutical formulation provides a standardised reference material for comparative studies across multiple research protocols.
Laboratory Research Applications
Scientific institutions studying protein synthesis pathways analyse boldenone’s interaction with androgen receptors in muscle tissue models. Veterinary researchers have extensively documented this compound’s effects on nitrogen retention and red blood cell production in animal studies. Endocrinology laboratories investigate its relatively mild estrogenic conversion compared to other anabolic compounds, making it valuable for comparative hormone pathway research. Pharmaceutical researchers examining long-acting injectable formulations study its undecylenate ester, which extends biological activity in experimental models. Our research chemical portfolio at Stroid UK Shop supports diverse scientific investigations, while our boldenone research collection provides standardised reference materials. Researchers also examine selective androgen receptor modulators and peptide compounds for comparative molecular pathway analysis.
Product Specifications
| Parameter | Specification |
|---|---|
| Chemical Name | 17β-Hydroxyandrost-1,4-dien-3-one undecanoate |
| CAS Number | 13103-34-9 |
| Molecular Formula | C₃₀H₄₄O₃ |
| Molecular Weight | 452.67 g/mol |
| Vial Volume | 10ml |
| Manufacturer | Beligas Pharmaceutical |
| Storage | Room temperature, protect from light |
| Solubility | Oil-based injectable solution |
Research Compliance Statement
This Equipoise (Boldenone) formulation is manufactured exclusively for in-vitro laboratory research purposes and is not intended for human consumption, veterinary use, or any therapeutic applications. Researchers must possess appropriate institutional authorisation and follow established laboratory safety protocols when handling this compound. All studies should be conducted within approved research facilities with proper waste disposal procedures. This product is restricted to qualified research institutions and is not suitable for personal use, dietary supplementation, or any non-research applications.
